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Abstract
Introduction: The aim of the present study was to examine the response of plasma orexin and ghrelin to the oral glucose
tolerance test (OGTT) in obese women without additional disease.
Material and methods: The study group comprised 15 obese women aged 30.4 ± 9.7 years of mean BMI 34.7 ± 3.8 kg/m2.
The measurements were performed after an overnight fast and 30, 60 and 120 minutes after the oral administration of
75 grams of glucose. Serum concentrations of ghrelin and orexin A were measured by an enzyme — linked immunosorbent
assay (ELISA) kit. Serum concentrations of insulin were measured by radioimmunoassay (RIA). Plasma glucose was deter-
mined by an enzymatic procedure. Body composition was determined by impedance analysis using Bodystat.
Results: We observed no significant differences between serum concentrations of ghrelin and orexin during OGTT. No
correlations were found between serum ghrelin and orexin concentrations and serum insulin and glucose concentrations
in any of the measurements.
Conclusion: Oral glucose administration did not change serum concentrations of ghrelin and orexin A in obese women
without additional disease.
(Pol J Endocrinol 2007; 58 (5): 422–425)
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Streszczenie
Wstęp: Celem badania była ocena zmiany stężeń oreksyny i greliny w surowicy podczas testu doustnego obciążenia glu-
kozą (OGTT, oral glucose tolerance test) u otyłych kobiet bez dodatkowych chorób towarzyszących.
Materiał i metody: Badana grupa składała się z 15 otyłych kobiet w wieku 30,4 ± 9,7 lat ze średnim BMI wynoszącym 34,7 ±
± 3,8 kg/m2. Próbki krwi pobrano rano na czczo, a następnie po 30, 60 i 120 minutach po doustnym podaniu 75 gramów
glukozy. Stężenie greliny i oreksyny A w surowicy oceniano metodą bioimpedancji (ELISA). Do pomiaru stężenia insuliny
w surowicy wykorzystano metodę radioimmunologiczną (RIA). Stężenie glukozy w osoczu określono metodą enzyma-
tyczną. Skład masy ciała określono, stosując analizę impedancji z użyciem aparatu Bodystat.
Wyniki: Nie stwierdzono istotnych różnic między stężeniem greliny i oreksyny w surowicy podczas OGTT. Nie wykaza-
no żadnych korelacji między stężeniem greliny i oreksyny w surowicy a stężeniem insuliny i glukozy.
Wnioski: Doustne podanie glukozy nie spowodowało zmiany stężeń greliny i oreksyny A w osoczu u otyłych kobiet bez
chorób towarzyszących.
(Endokrynol Pol 2007; 58 (5): 422–425)
Słowa kluczowe: otyłość, grelina, oreksyna
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Introduction
A large number of studies have recently been performed
in order to elucidate the regulation of appetite and food
intake. Currently two peptides, ghrelin and orexin, are
known to participate in the regulation of appetite.
The peptide hormone ghrelin is predominantly pro-
duced by the stomach, although its expression has also
been demonstrated in the bowel, pancreas, kidneys,
placenta, gonads, pituitary, hypothalamus and adipo-
se tissue [1, 2, 3].
Ghrelin increases expression of hypothalamic neuro-
peptide Y (NPY) and stimulates food intake in both ro-
dents and human [4]. Circulating ghrelin levels are incre-
ased by fasting and energy restriction and are decreased
by food intake, glucose, insulin and somatostatin [5].
The mean normal serum ghrelin level in humans is
117 ± 37 fmol/ml [6]. A previous study revealed that
serum concentrations of ghrelin are reduced in obese
humans [7] and that weight loss increased serum con-
centrations of ghrelin [8].
Orexins A and B are pairs of neuropeptides that are
expressed in the lateral hypothalamic area [9]. Orexin
receptors are present in the hypothalamus, pancreas
and gut [10]. Kastin et al. [11] revealed that orexins can
pass the blood-brain barrier and are expressed in the
peripheral tissues. Centrally administered orexin A sti-
mulates food intake in rodents [12]. Peripherally admi-
nistered orexin A increases insulin secretion [13].
Results obtained by Adam et al. [14] revealed that
plasma orexin A levels are decreased in obese individuals.
The aim of the present study was to examine the
response of plasma orexin and ghrelin to the oral glu-
cose tolerance test (OGTT) in obese women without
additional disease.
Material and methods
The study group consisted of 15 obese women with
a mean age of 30.4 ± 5.7 years and a mean body mass
index (BMI) of 34.7 ± 3.8 kg/m2. The study group is cha-
racterised in Table I.
All the obese subjects included in the study were
diagnosed as having simple obesity without additional
disease. All patients had serum concentrations of glu-
cose and insulin within the reference ranges. The exc-
lusion criteria were evidence of present or recent (du-
ring the preceding three months) infectious disease,
fever and drug therapy. The study was conducted after
obtaining the informed consent of all the subjects and
was approved by the local ethics committee.
Body weights and heights were measured, and BMI
calculated as weight in kilograms divided by the squ-
are of the height in metres. Body composition was de-
termined by impedance analysis using a Bodystat ana-
lyser.
After an overnight fast 6–8 ml samples of venous
blood were collected 30, 60 and 120 minutes after oral
administration of 75 grams of glucose. The blood sam-
ples were collected according to the recommendation
of the kit manufacturer. The blood for both ghrelin and
orexin A measurements was collected into Lavender
Vacutainer tubes containing EDTA. The Lavender Va-
cutainer tubes were then gently rocked several times
immediately after the collection of blood for anti-coagu-
lant. Next the blood was transferred from the Lavender
Vacutainer tubes to centrifugal tubes containing aprotinin
(0.6 TIU/ml of blood) and gently rocked several times to
inhibit the activity of proteinases. The plasma was col-
lected after centrifugation of the blood at 1,600 × g for
15 minutes at 4°C. The plasma obtained was drawn into
plastic vials, and stored at –80°C until the time of assay.
Plasma glucose was determined by an enzymatic
procedure using a commercially available test kit (Cor-
may). Insulin was determined by radioimmunoassay
(RIA) (Diagnostic Products Corporation, USA) with
a lower limit of sensitivity of 1.2 mIU/ml and intra-as-
say and inter-assay coefficients with variations of 5.2%
and 5.8% respectively.
The blood plasma of ghrelin was measured using
a commercially available highly sensitive enzyme-lin-
ked immunosorbent assay (ELISA) kit (Phoenix Phar-
maceuticals USA). The sensitivity of the ghrelin assay is
typically less than 6.0 pg/ml. The mean intra-assay co-
efficient of variance was < 6.0% and the mean inter-
assay coefficient of variance was < 9.0%.
The blood plasma of orexin A was measured using
a commercially available highly sensitive enzyme-lin-
ked immunosorbent assay (ELISA) kit (Phoenix Phar-
maceuticals USA). The sensitivity of the orexin assay is
typically less than 37.0 pg/ml. The mean intra-assay co-
efficient of variance was < 5.0% and the mean inter-
assay coefficient of variance was < 14.0%.
Table I
Characteristics of study subjects
Tabela I
Charakterystyka badanych
N = 15
Weight [kg] 91.4±13.1
BMI [kg/m2] 34.7±3.8
Body fat [kg] 39.7±9.7
Body fat (%) 42.9±4.5
Fat-free mass [kg] 51.7±4.7
Fat-free mass (%) 57.1±4.5
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Statistical analysis
All text and table values are expressed as means ± SD.
Changes in the study parameters between baseline and
30, 60 and 120 minutes were evaluated using a paired
t test. The relationships between the study parameters
were examined by Pearson’s correlation analysis.
A p value < 0.05 was considered statistically significant.
Results
The responses of plasma orexin, ghrelin, insulin and
glucose to the OGTT are presented in Table II.
We did not observe any significant difference be-
tween plasma concentrations of ghrelin and orexin du-
ring OGTT.
No correlations were found between body mass, BMI
and body composition and serum ghrelin and orexin A
concentrations. We did not observe any correlation be-
tween plasma ghrelin and orexin A, serum insulin and
glucose concentrations in any of the measurements.
Discussion
As described above, recent studies have shown that cir-
culating ghrelin levels are decreased by glucose, insu-
lin, and somatostatin [5]. In our study we observed
a tendency to a decrease in ghrelin concentration
60 minutes after oral administration of glucose. This is
in agreement with previous observations, which reve-
aled that ghrelin is expressed in the oxyntic mucosal
cells of an empty stomach and that its concentration
rises sharply before a meal and decreases one hour after
a meal [15–17]. Because it was glucose and not
a meal that was administered, it seems that the inhibi-
ting effect of glucose on ghrelin release may be weaker
than the inhibiting effect of a meal. This is in agreement
with the findings reported by Foster-Schubert et al. [18]
that the carbohydrate beverage was the most effective
in ghrelin inhibition, whereas the fat beverage was less
effective. Experimental study in rats has also shown
a decrease in ghrelin after nutrient infusion into either
the proximal duodenum or proximal jejunum [19]. The
effect was more pronounced after infusion of amino
acids and glucose than after infusion of lipids [19]. On
the other hand, Broglio et al. [20] revealed a significant
decrease in ghrelin levels in obese subjects 60 minutes
after the glucose load during OGTT. However, they
performed OGTT with 100 g of glucose and we used
75 g of glucose.
We did not observe any significant changes in se-
rum concentrations of ghrelin during OGTT. This agrees
with the findings of Callahan et al. [21] that both the
depth and duration of postprandial ghrelin suppres-
sion were directly related to energy load, with more
energy as a percentage of total daily energy require-
ments suppressing ghrelin to a greater degree. Contra-
dictory results were obtained by Cappiello et al. [22].
A significant decrease in ghrelin (25–40%) during OGTT
and significant negative correlations between serum
ghrelin levels and BMI and insulin levels were obse-
rved in both the obese and lean groups. It seems that
differences between our results and the observations
of Cappiello et al. are caused by differences in the cha-
racteristics of the study groups. Cappiello et al. studied
a small group of obese subjects (one man and three
women) and a small control group (six women) and
both groups were older than our study groups. More-
over, Greenman et al [23] showed that ghrelin respon-
se to nutrients is modulated by gender.
A correlation between fasting ghrelin level and BMI
was also observed by Stock et al. [16]. However, their
study group consisted of adolescents. On the other
hand, body fat mass was not determined in either of
the studies cited and our previous study [8] revealed
that body fat rather than BMI correlated with ghrelin
Table II
Changes in the study parameters during OGTT
Tabela II
Zmiany badanych parametrów w czasie OGTT
Minutes after oral administration of 75 grams of glucose
0’ 30’ 60’ 120’
Ghrelin [pg/ml] 77.4±49.5 80.6±62.7 69.8±48.7 73.7±39.2
Orexin A [pg/ml] 372.3±84.1 405.6±81.8  397.6±109.9 435.5±121.1
Insulin [mlU/ml] 16.0±10.5 115.1±49.1*** 111.2±59.0*** 117.5±49.1***
Glucose [mg/dl] 94.8±8.5 132.0±22.9*** 132.7±33.7*** 121.9±25.1**
**p < 0.005;***p < 0.001
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levels. However, Bacha et al. [24] observed negative
correlations between ghrelin levels and both BMI and
body fat mass in obese children. They also showed a
significant decrease in ghrelin levels 60 min. after glu-
cose load during OGTT (24%).
Nowak et al. [13] revealed that peripherally admini-
stered orexin A increases insulin secretion in rats. On
the other hand, Chang et al. [25] observed that circula-
ting triglycerides stimulate hypothalamic neurons to
synthesis of specific feeding stimulatory peptides, inc-
luding orexin A. In our study we observed a tendency
to an increase in orexin A concentration 120 minutes
after oral administration of glucose. Therefore it seems
that high concentrations of carbohydrate as well as li-
pids may stimulate hypothalamic synthesis of orexin
A, but that the stimulation is weaker than that exerted
by lipids.
We did not observe any correlations between serum
ghrelin and orexin A concentrations in any of the me-
asurements, which is interesting, as both ghrelin and
orexin A inducing food intake involve the neuropepti-
de Y pathway [4, 26].
Conclusions
Oral glucose administration did not change serum con-
centrations of ghrelin and orexin in obese women wi-
thout additional disease.
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